PRAXIS INVESTMENT MANAGEMENT INC
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1056825
GOSHEN, IN
Position in INDV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$208,063
New position
Shares Held
5,071
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#249
of 334 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRAXIS INVESTMENT MANAGEMENT INC holds $2,979,923 across 8 Drug Manufacturers - Specialty & Generic names. INDV ranks #8 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,380 | $747,725 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
3,074 | $518,091 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
17,250 | $424,522 | |
| 4 | ALKS |
Alkermes plc.
|
5,798 | $303,815 | |
| 5 | ZTS |
Zoetis Inc.
|
3,822 | $274,648 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
7,659 | $265,537 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
2,141 | $237,522 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
5,071 | $208,063 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $208,063 | 5,071 | Shares | Sole | 2026-08-04 | |
| No filing history on record for this holder in this stock. | ||||||